6 min listen
Company Overview: Greenwich LifeSciences (GLSI)
FromSchwab Network
ratings:
Length:
7 minutes
Released:
Jul 20, 2021
Format:
Podcast episode
Description
Greenwich LifeSciences (GLSI) is a clinical stage biopharmaceutical company that develops immunotherapy treatments for cancer. Snehal Patel, CEO and Board Member of Greenwich LifeSciences, gives an overview of the company, as well as talking about what to know about the GP2 treatment. Greenwich LifeSciences stock is up 10% in 2021. Tune in to find out more.
Released:
Jul 20, 2021
Format:
Podcast episode
Titles in the series (100)
Historical Look At S&P 500 During Election Years by Schwab Network